Ascolta mensilmente mentre esperti discutono articoli chiave da JCO Precision Oncology, ospitato dal Dr. Abdul Rafeh Naqash. Rimani informato sulle ultime novità nella cura del cancro di precisione.
Proteomics Predictor for Immunotherapy Benefit
21 mins • Jan 15, 2025
Charts
- 66Decreased by 14
- 178NEW
- 181NEW
- 86NEW
- 11NEW
Episodi recenti
Jan 15, 2025
Proteomics Predictor for Immunotherapy Benefit
21 mins
Dec 18, 2024
Transcriptome and ctDNA Associates with Pembrolizumab Benefit
23 mins
Nov 27, 2024
JCO Precision Oncology Article Insights: Germline Pathogenic Variants in Renal Cell Carcinoma
10 mins
Nov 15, 2024
Uptake of Aspirin Chemoprevention in Lynch Syndrome
31 mins
Oct 30, 2024
JCO PO Article Insights: Talazoparib in Solid Tumors with BRCA1/2 Mutation
7 mins
Lingua
Inglese
Paese
Colombia
Feed Host
Sito web
Feed
Request an Update
Updates may take a few minutes.